Briefing

Industry news

Industry briefing

NEWS

Merck and Moderna partner to develop and sell cancer vaccine

Merck has extended its partnership with Moderna to jointly develop and sell mRNA-4157/V940, an investigational personalised cancer vaccine

news

WHO grants prequalification for Sinovac’s varicella vaccine

The World Health Organization (WHO) has granted prequalification for Sinovac Biotech’s live attenuated varicella vaccine

Briefing

Instil Bio halts subject enrolment in trials due to manufacturing issues 

Instil Bio has voluntarily halted subject enrolment in its clinical trials analysing ITIL-168 and ITIL-306 due to manufacturing-related issues 

Industry news

Industry briefing

11/23/2022 21:29:28
  • Home | What Rishi Sunak can do for the UK pharma industry
  • In this issue
  • Contents
  • CSafe
  • Tripletree
  • Briefing
  • Industry news
  • The pharma industry briefing
  • BEA Technologies
  • Mimotopes Company Insight
  • Mimotopes
  • Comment
  • GSK speeds up the race to market first RSV vaccine for older adults
  • Biden’s directive on foreign biotech investments impacts manufacturers
  • Novo Nordisk targets FDA approval for once-weekly insulin after Phase III data
  • ‘Twindemic’ risks warrant immediate steps in Europe and the US
  • A game of two halves for Roche’s recently approved wet AMD assets
  • Dr. Paul Lohmann
  • Nipro
  • In Depth
  • What Rishi Sunak can do for the UK pharma industry
  • Inside the European mass shift to data-driven health solutions
  • Chronic drug shortages signal difficult outlook for cardiovascular care
  • Can gene therapies for haemophilia defend their high price tags?
  • Trial termination analysis unveils a silver lining for patient recruitment
  • New dawn for the EU's joint procurement crisis response
  • Skyepharma
  • Bio Image Systems Inc.
  • In Data
  • The pharma industry found it easier to fill AI vacancies in Q3 2022
  • Internet of things hiring levels in the pharma dropped in October 2022
  • Artificial intelligence hiring levels in the pharma dropped in October 2022
  • Baxter
  • Events
  • Next issue